It is engineered to have three antigen-binding sites to bind to tumor-specific antigens on tumor cells, CD3; a T cell receptor (TCR) on T cells, and CD28; co-stimulatory molecules, also expressed on T cells. The gene discussed is CD28; the disease is neoplasm.